| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $81K | +153.1% | — |
| Cost of Revenue | $5K | -82.1% | — |
| Gross Profit | $76K | +1800.0% | — |
| R&D Expense | $2.1M | -15.3% | +36.7% |
| SG&A Expense | $1.3M | -43.6% | -15.7% |
| Operating Income | -$3.2M | +27.1% | -12.4% |
| Pre-tax Income | -$3.9M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $881K | -23.5% | -50.6% |
| Current Assets | $2.4M | -31.1% | -37.0% |
| Total Assets | $3.2M | -24.1% | -24.6% |
| Current Liabilities | $5.8M | +46.0% | +191.9% |
| Total Liabilities | $6.2M | +40.6% | +206.0% |
| Stockholders' Equity |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$6.3M | — | — |
| Capital Expenditures | $105K | — | — |
| Investing Cash Flow | -$105K | — | — |
| Financing Cash Flow | $3K | — | — |
| Free Cash Flow | -$6.4M | — | — |
| -37.9% |
| Income Tax | -$24K | -2500.0% | — |
| Net Income | -$3.9M | -63.3% | -37.9% |
| EPS (Basic) | -$0.45 | -50.0% | +47.7% |
| EPS (Diluted) | -$0.45 | -50.0% | +47.7% |
| -$3.0M |
| -2224.4% |
| -229.5% |